Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,906 | 319 | 96.8% |
| Education | $196.44 | 20 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,055 | 65 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $819.79 | 51 | $0 (2024) |
| Amgen Inc. | $760.25 | 34 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $460.25 | 28 | $0 (2024) |
| GlaxoSmithKline, LLC. | $349.26 | 26 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $346.71 | 23 | $0 (2024) |
| Novo Nordisk Inc | $274.31 | 17 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $259.97 | 7 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $237.38 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $214.36 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $836.25 | 43 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($145.60) |
| 2023 | $1,184 | 53 | Amgen Inc. ($289.58) |
| 2022 | $686.20 | 41 | E.R. Squibb & Sons, L.L.C. ($235.15) |
| 2021 | $944.02 | 55 | PFIZER INC. ($196.03) |
| 2020 | $411.84 | 24 | Amgen Inc. ($85.15) |
| 2019 | $894.37 | 50 | PFIZER INC. ($277.08) |
| 2018 | $758.51 | 50 | PFIZER INC. ($210.78) |
| 2017 | $386.66 | 23 | PFIZER INC. ($139.47) |
All Payment Transactions
339 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $59.04 | General |
| Category: DIABETES | ||||||
| 12/20/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.52 | General |
| Category: Cardiovascular | ||||||
| 12/20/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $1.27 | General |
| Category: Cardiovascular | ||||||
| 12/09/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Genetic Disease | ||||||
| 12/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Neuroscience | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $7.32 | General |
| Category: Cardiovascular | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $5.41 | General |
| Category: Cardiovascular | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Gastroenterology | ||||||
| 11/01/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.27 | General |
| Category: Cardiovascular | ||||||
| 10/28/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Gastroenterology | ||||||
| 10/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $2.38 | General |
| Category: Gastroenterology | ||||||
| 10/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: Biological | ||||||
| 09/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Inflammation | ||||||
| 09/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Inflammation | ||||||
| 08/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Biological | ||||||
| 08/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Gastroenterology | ||||||
| 08/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/29/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.81 | General |
| Category: Cardiovascular | ||||||
| 07/01/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/24/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 683 | 1,288 | $156,140 | $50,431 |
| 2022 | 19 | 1,096 | 1,868 | $204,148 | $77,611 |
| 2021 | 18 | 1,002 | 1,840 | $178,196 | $70,531 |
| 2020 | 20 | 1,096 | 1,999 | $179,923 | $63,047 |
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 149 | 273 | $69,615 | $24,725 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 121 | 178 | $40,940 | $11,366 | 27.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 67 | 67 | $25,125 | $9,044 | 36.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 189 | 285 | $7,125 | $2,363 | 33.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 26 | 28 | $5,180 | $1,139 | 22.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 53 | 91 | $3,185 | $866.32 | 27.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 43 | $2,150 | $441.04 | 20.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 27 | 281 | $1,200 | $219.33 | 18.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $1,040 | $157.17 | 15.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 15 | 29 | $580.00 | $110.65 | 19.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 195 | 377 | $91,160 | $34,184 | 37.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 101 | 101 | $37,875 | $13,824 | 36.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 107 | 163 | $33,430 | $10,414 | 31.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 66 | 68 | $4,760 | $4,639 | 97.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 16 | 16 | $7,600 | $4,449 | 58.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 67 | 69 | $3,450 | $2,151 | 62.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 13 | 13 | $1,770 | $1,577 | 89.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 75 | 134 | $3,655 | $1,285 | 35.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 35 | 35 | $1,750 | $1,098 | 62.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 226 | 348 | $7,030 | $1,019 | 14.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 33 | 71 | $3,345 | $834.86 | 25.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 15 | $2,730 | $657.78 | 24.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 12 | 12 | $600.00 | $417.93 | 69.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 30 | 313 | $1,260 | $264.64 | 21.0% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 34 | 51 | $1,020 | $199.10 | 19.5% |
About Dr. Steven Maness, M.D
Dr. Steven Maness, M.D is a Internal Medicine healthcare provider based in Gresham, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1700872785.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Maness, M.D has received a total of $6,102 in payments from pharmaceutical and medical device companies, with $836.25 received in 2024. These payments were reported across 339 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,906).
As a Medicare-enrolled provider, Maness has provided services to 3,877 Medicare beneficiaries, totaling 6,995 services with total Medicare billing of $261,621. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Gresham, OR
- Active Since 09/23/2005
- Last Updated 10/14/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1700872785
Products in Payments
- ELIQUIS (Drug) $1,022
- CHANTIX (Drug) $338.27
- Otezla (Drug) $318.11
- EVENITY (Biological) $276.28
- REXULTI (Drug) $237.38
- ENTRESTO (Drug) $201.90
- XARELTO (Drug) $194.38
- SHINGRIX (Biological) $190.31
- INVOKANA (Drug) $186.69
- FARXIGA (Drug) $173.92
- LYRICA (Drug) $151.59
- XIFAXAN (Drug) $145.60
- WATCHMAN (Device) $139.07
- Aimovig (Biological) $131.84
- REZUM (Device) $120.90
- JARDIANCE (Drug) $119.07
- Ozempic (Drug) $117.83
- UBRELVY (Drug) $108.22
- APTIMA (Device) $100.31
- CAMZYOS (Drug) $99.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Gresham
Edward Cheng, M.d,, M.D,
Internal Medicine — Payments: $39,176
Dr. Avnish Tripathi, M.d., Ph.d., M.p.h, M.D., PH.D., M.P.H
Internal Medicine — Payments: $12,554
Jennifer Rodriguez, M.d, M.D
Internal Medicine — Payments: $10,858
Angela Gibbs, Md, MD
Internal Medicine — Payments: $1,551
Craig Davis, Md, MD
Internal Medicine — Payments: $804.46
Shanna Cheng
Internal Medicine — Payments: $510.26